ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,721, issued on April 15, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Indazole carboxamides as kinase inhibitors" was invented by Jie Chen (Cambridge, Mass.), Carolyn Diane Dzierba (Medford, Mass.), Junqing Guo (Princeton, N.J.), Amy C. Hart (Littleton, Colo.), William J. Pitts (Newtown, Pa.) and Sing-Yuen Sit (Meriden, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein."

The patent was filed on Oct. 2, 2020, u...